Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

What Will Part D Prices Look Like in 2007?

This article was originally published in RPM Report

Executive Summary

Big Pharma companies say its too early to tell what prices will look like under Medicare Part D next year. That is in part because they can't be sure yet what prices they will get in 2006. That won't be clear until claims are reconciled this fall.

You may also be interested in...



Medicare Rebates: Bigger is Better, But is Big Government Best?

An inspector General report takes the first public look at rebating under Medicare Par D.For Henry Waxman the message is that private negotiation isn't working to capture deep enough discounts. But the more important message for sponsors is that the report shows CMS remains firmly committed to the private sector drug insurance model.

Medicare Rebates: Bigger is Better, But is Big Government Best?

An inspector General report takes the first public look at rebating under Medicare Par D.For Henry Waxman the message is that private negotiation isn't working to capture deep enough discounts. But the more important message for sponsors is that the report shows CMS remains firmly committed to the private sector drug insurance model.

A Second-Half Story: Medicare Plans, Wall Street and the Future of Part D

The three most aggressive Medicare Part D bidders are thrilled with how their bets are paying off so far. The next challenge: translating market share into profits and proving to investors that they can make Medicare pay in the long term.

Related Content

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

PS080138

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel